i-FACTOR Peptide Enhanced Bone Graft exhibits superior clinical outcomes compared to autograft (the ‘gold standard’) in anterior cervical discectomy and fusion.

i-FACTOR Peptide Enhanced Bone Graft is statistically superior to autologous bone in facilitating formation of bridging bone inside PLIF cages.

i-FACTOR Peptide Enhanced Bone Graft demonstrates a high fusion rate and clinical improvements  comparable to ALIF using autograft of BMP, but a with superior safety profile and lower cost.

i-FACTOR Peptide Enhanced Bone Graft provides a high level of bone consolidation in challenging long-bone non-union and delayed unions.

i-FACTOR Peptide Enhanced Bone Graft provides a higher rate of fusion in transforaminal lumbar interbody fusion compared to Actifuse and Vitoss.

  • Berg AJ, et al. Transforaminal lumbar interbody fusion rates with Actifuse, i-FACTOR and Vitoss BA synthetic bone grafts, ISASS 2014 Annual Meeting and EFORT 2014 Congress (poster)

i-FACTOR Peptide Enhanced Bone Graft provides reliable fusion in cervical interbody fusion (80% fused and 17% progressing to fusion at 26 weeks follow-up).

  • Berg AJ, et al. Cervical interbody fusion rates with i-FACTOR Peptide Enhanced Bone Graft, ISASS 2014 Annual Meeting and EFORT 2014 Congress (poster)

i-FACTOR Peptide Enhanced Bone Graft restores near normal bone porosity and trabecular orientation in ACDF.

  • Kesteloot G, et al. Three dimensional remodeling of i-FACTOR Peptide Enhanced Bone Graft substitute in cervical fusions, Belgian Society of Neurosurgery 2016 Annual Meeting (poster)

The synthetic P-15 peptide exhibits greater defect fill compared to freeze dried bone allograft and open flap debridement in periodontal osseous defects.

The synthetic P-15 peptide exhibits greater defect fill and superior clinical results compared to anorganic hydroxyapatite bone matrix in periodontal osseous defects.

The synthetic P-15 peptide is effective in the long-term management of infrabony defects after three-year follow-up.

The synthetic P-15 peptide offered significantly improved clinical outcomes compared to open flap debridement.